ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0132

Hospitalization Rates Among Patients with Systemic Lupus Erythematosus: A Population Based Study

Jesse Dabit1, Mehmet Hocaoglu2, Maria Valenzuela-Almada3, Shirley-Ann Osei-Onomah1, Sebastian Vallejo-Ramos1, Rachel Giblon1, Kurt Greenlund4, Kamil Barbour4, Cynthia Crowson5 and Ali Duarte-Garcia1, 1Mayo Clinic, Rochester, MN, 2University of Maryland Medical Center, Midtown Campus, Baltimore, MD, 3Division of Rheumatology, Mayo Clinic, Rochester, MN, 4Centers for Disease Control, Atlanta, GA, 5Mayo Clinic, Eyota, MN

Meeting: ACR Convergence 2021

Keywords: Epidemiology, Healthcare Services, Hospitalization Rates, population studies, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Health Services Research Poster I: Lupus, Inflammatory Arthritis, & More (0128–0148)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune multiorgan disease associated with significant morbidity and mortality. Although the survival rate for SLE patients has improved, hospitalization rates and healthcare utilization among SLE patients remain higher than the general population. By using a population-based cohort, we describe hospitalization rates, causes and risk factors among SLE patients compared to non-SLE patients between 2015 and 2020.

Methods: Using an established population-based research infrastructure that links the medical records of all individuals in a geographically well-defined 27-county US population, we identified SLE cases meeting the 2019 ACR/EULAR classification criteria. SLE patients who were residents in the 27-county region on January 1, 2015 were included. Patients with SLE were matched by age, sex, race/ethnicity and county of residence to non-SLE patients and were followed until 12/2020. Variables included were age, sex, race/ethnicity, number of hospitalizations, length of stay (LOS) and primary discharge diagnosis. Chi-square and Kruskal-Wallis rank sum tests were used to assess difference in characteristics between cases and controls. Hospitalization data were analyzed using person-year methods and rate ratios were obtained from Poisson models.

Results: We identified 479 SLE patients and 479 comparators. Mean age of SLE patients was 53.2 (SD 16.2) years, 82% were females and 85% were white (Table 1). Between 2015 and 2020, the hospitalization rate of SLE patients was 26.2/100 person-years compared to 9.3/100 person-years among comparators (rate ratio (RR) 2.83; 95% confidence interval (CI) 2.43-3.31; Table 2). LOS was higher among SLE patients (median 4 vs. 3 days; p=0.001). SLE patients were hospitalized at a significantly higher rate than subjects without SLE in 10 of 15 diagnosis categories (Table 2). The highest RR was observed for hematologic diseases (RR 11.38; 95% CI 3.24-159.95) followed by respiratory diseases (RR 4.88; 95% CI 3.00-8.75) and genitourinary diseases (RR 4.73; 95% CI 2.23-12.84). SLE hospitalization rates compared to non-SLE comparators were highest among males (RR 3.18; 95% CI 2.31-4.5), those with SLE duration < 5 years since diagnosis (RR 3.05; 95% CI 2.59-3.62) and age 50-64 years (RR 4.5; 95% CI 3.37-6.2) (Table 3).

Conclusion: SLE patients had nearly 3-fold more hospitalizations than comparators with an increased risk of hospitalization for most diagnosis categories.

Table 1. Demographic and hospitalization characteristics among SLE patients and comparators

Table 2. Rate of hospitalization by primary discharge diagnosis using the Clinical Classifications Software among SLE patients and comparators

Table 3. Rate of hospitalizations among SLE patients and comparators by sex, age and disease duration


Disclosures: J. Dabit, None; M. Hocaoglu, None; M. Valenzuela-Almada, None; S. Osei-Onomah, None; S. Vallejo-Ramos, None; R. Giblon, None; K. Greenlund, None; K. Barbour, None; C. Crowson, None; A. Duarte-Garcia, None.

To cite this abstract in AMA style:

Dabit J, Hocaoglu M, Valenzuela-Almada M, Osei-Onomah S, Vallejo-Ramos S, Giblon R, Greenlund K, Barbour K, Crowson C, Duarte-Garcia A. Hospitalization Rates Among Patients with Systemic Lupus Erythematosus: A Population Based Study [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/hospitalization-rates-among-patients-with-systemic-lupus-erythematosus-a-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hospitalization-rates-among-patients-with-systemic-lupus-erythematosus-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology